| Title | Consultation response to the Medicines and Healthcare Products Regulatory Agency (MHRA) on 'Consultation MLX 336 - Patient Group Directions (1) Proposals for changes to the legislation governing the supply of Controlled Drugs by nurses and pharmacists working under Patient Group Directions (2) Proposals to expand the use of Patient Group Directions in the independent healthcare sector in Northern Ireland (3) Proposals to correct a technical error on use of Patient Group Directions in the private sector' |